Marienn Reti
Overview
Explore the profile of Marienn Reti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
529
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cegledi A, Kiraly A, Varkonyi A, Tasnady S, Andrikovics H, Fekete M, et al.
Pharmaceuticals (Basel)
. 2025 Jan;
17(12.
PMID: 39770564
Background: Thrombotic microangiopathy (TMA) is a potentially life-threatening complication associated with carfilzomib, a proteasome inhibitor approved for treating multiple myeloma. TMA typically presents within the initial months of treatment; however,...
2.
Szabo D, Balogh A, Gopcsa L, Giba-Kiss L, Lakatos G, Paksi M, et al.
RMD Open
. 2024 Oct;
10(4).
PMID: 39448205
We report the case of long-term persisting rheumatoid arthritis (RA), treated with CD20-CD19 CAR-T when it became associated with diffuse large B cell lymphoma (DLBCL), resulting in a sustained drug-free...
3.
Demeter F, Bihari G, Vadicsku D, Sinkovits G, Kajdacsi E, Horvath L, et al.
Int J Mol Sci
. 2024 Sep;
25(18).
PMID: 39337495
Thromboinflammation/immunothrombosis plays a role in several diseases including thrombotic thrombocytopenic purpura (TTP) and COVID-19. Unlike the extensive research that has been conducted on COVID-19 cytokine storms, the baseline and acute...
4.
Szabo B, Remenyi P, Tasnady S, Korozs D, Gopcsa L, Reti M, et al.
J Clin Med
. 2023 Aug;
12(15).
PMID: 37568402
The optimal approach for adult patients hospitalized with severe and critical coronavirus disease 2019 (COVID-19), non-responsive to antiviral and immunomodulatory drugs, is not well established. Our aim was to evaluate...
5.
Gopcsa L, Reti M, Andrikovics H, Bobek I, Beko G, Bogyo J, et al.
Geroscience
. 2023 Jul;
46(1):1083-1106.
PMID: 37414968
The COVID-19 pandemic has exacerbated mortality rates among immunocompromised patients, accentuating the need for novel, targeted therapies. Transplant recipients, with their inherent immune vulnerabilities, represent a subgroup at significantly heightened...
6.
Teszak T, Assabiny A, Kiraly A, Tarjanyi Z, Parazs N, Szakal-Toth Z, et al.
Transpl Immunol
. 2023 May;
79:101853.
PMID: 37196865
Despite novel immunosuppressive (IS) protocols, adverse effects of IS drugs continue to have notable negative impact on patient and cardiac allograft survival after heart transplantation (HTx). Therefore, IS regimens with...
7.
Hurler L, Szilagyi A, Mescia F, Bergamaschi L, Mezo B, Sinkovits G, et al.
Front Immunol
. 2023 Apr;
14:1162171.
PMID: 37051252
Introduction: While complement is a contributor to disease severity in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, all three complement pathways might be activated by the virus. Lectin pathway...
8.
Lopert P, Abdelrahman S, Graybill C, Rhodes J, Dierickx D, Schafer R, et al.
J Clin Apher
. 2023 Jan;
38(4):396-405.
PMID: 36655281
Background: For the past 30 years, white blood cell depletion (WBCD) or leukocytapheresis has been conducted to rapidly reduce excessive circulating white blood cell (WBC) concentrations in patients at risk...
9.
Kiss-Dala N, Szabo B, Lakatos B, Reti M, Szlavik J, Valyi-Nagy I
Geroscience
. 2022 Nov;
44(5):2427-2445.
PMID: 36367599
Convalescent plasma therapy might be a feasible option for treatment of novel infections. During the early phases of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic, several promising results were...
10.
Henry B, Sinkovits G, Szergyuk I, de Oliveira M, Lippi G, Benoit J, et al.
Front Med (Lausanne)
. 2022 May;
9:796109.
PMID: 35572977
Background: Dysregulation of complement system is thought to be a major player in development of multi-organ damage and adverse outcomes in patients with coronavirus disease 2019 (COVID-19). This study aimed...